http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3aab4b6086d0431c8ef4d4294fd1b6a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Papadimitrakopoulou |
| name | Vassiliki Papadimitrakopoulou |
| given-name | Vassiliki |
| organization-name | Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Authors' Affiliations: Departments of 1Thoracic/Head and Neck Medical Oncology, 2Biostatistics, 3Dental Oncology, 4Pathology, 5Pharmacy-Pharmacology Research, and 6Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas and 7Ito En Ltd., Central Research Institute, Tokyo, Japan 2Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston Department of Thoracic‐Head & Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA; Global Product Development Oncology, Pfizer, Inc. New York New York USA From the Departments of Thoracic/Head and Neck Medical Oncology, Head and Neck Surgery, Radiation Oncology, Biostatistics, Radiology, and Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Division of Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX; Currently: Pfizer, Inc, New York, NY Pfizer, Inc, New York, NY 1Thoracic/Head and Neck Oncology and Departments of Vassiliki Papadimitrakopoulou, J. Jack Lee, Ignacio I. Wistuba, Anne S. Tsao, Frank V. Fossella, Neda Kalhor, Sanjay Gupta, Lauren Averett Byers, Julie G. Izzo, Ximing Tang, Ferdinandos Skoulidis, Don L. Gibbons, Li Shen, Caimiao Wei, Lixia Diao, S. Andrew Peng, Jing Wang, Alda L. Tam, John V. Heymach, and Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, TX; Scott N. Gettinger, Sarah B. Goldberg, Ja Seok Koo, and Roy S. Herbst, Yale University, New Haven, CT; Vincent A. Miller,... From the Departments of Thoracic/Head and Neck Medical Oncology, Diagnostic Imaging, Head and Neck Surgery, Biostatistics, Radiation Oncology, and Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Division of Medical Oncology, Vanderbilt University, Nashville, TN; and Head and Neck Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Jonathan W. Goldman, University of California Los Angeles; Ronald B. Natale, Cedars-Sinai Medical Center, Los Angeles; Vlada Melnikova, Aleksandra Franovic, and Mark Erlander, Trovagene, San Diego; Karen Reckamp, City of Hope Comprehensive Cancer Center, Duarte; Sai-Hong Ignatius Ou, University of California Irvine School of Medicine, Orange; Joel W. Neal and Heather A. Wakelee, Stanford University, Stanford, CA; Chris Karlovich, Darrin Despain, Sergey Yurasov, Jason B. Litten, and Mitch Raponi, Clovis... Anne S. Tsao, Ignacio Wistuba, Dianren Xia, Lauren Byers, Lixia Diao, Jing Wang, Vassiliki Papadimitrakopoulou, Ximing Tang, Wei Lu, Zhi Tan, Shuxing Zhang, Monique Nilsson, and John V. Heymach, The University of Texas MD Anderson Cancer Center, Houston, TX; Humam Kara, American University of Beirut, Beirut, Lebanon; and Dimitry N. Grigoryev, Myvizhi Esai Selvan, and Zeynep H. Gümüş, Icahn School of Medicine at Mount Sinai, New York, NY. 3MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Thoracic/Head and Neck Medical Oncology, 2Experimental Therapeutics, 3Biostatistics, 4Head and Neck Surgery, 5Pathology, and 6Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas University of Texas M.D. Anderson Cancer CenterHouston Texas USA Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX MD Anderson Cancer Center, Houston, Texas 77030, USA. vpapadim@mdanderson.org From the Royal Marsden Hospital, Sutton, Surrey; Queen Elizabeth Hospital, Birmingham, United Kingdom; Institut Gustave-Roussy, Villejuif, France; Sarah Cannon Research Institute, Nashville, TN; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Novartis Pharma AG; and Novartis Institutes for BioMedical Research, Oncology, Basel, Switzerland Authors' Affiliations: 1Departments of Thoracic/Head and Neck Medical Oncology, 2Pathology, 3Biostatistics, and 4Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Winship Cancer Center, Emory University, Atlanta, Georgia; 6Dana-Farber Cancer Institute, Boston, Massachusetts; and 7University of Maryland, Baltimore, Maryland. 1The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas MD Anderson Cancer Center, Houston, TX From the Departments of Thoracic/Head and Neck Medical Oncology, Radiation Oncology, and Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 2Thoracic/Head and Neck Medical Oncology, Authors' Affiliations: Departments of 1Thoracic/Head and Neck Medical Oncology, 2Pathology, and 3Biostatistics and Applied Mathematics, and 4Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; Departments of 5Otolaryngology and 6Pharmacology and Chemical Biology, University of Pittsburgh, and 7University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; and 8Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland |
Incoming Links
Total number of triples: 88.